BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 27858212)

  • 1. Hepatosplenic volumetric assessment at MDCT for staging liver fibrosis.
    Pickhardt PJ; Malecki K; Hunt OF; Beaumont C; Kloke J; Ziemlewicz TJ; Lubner MG
    Eur Radiol; 2017 Jul; 27(7):3060-3068. PubMed ID: 27858212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of Liver Surface Nodularity Quantification on MDCT as a Noninvasive Biomarker for Staging Hepatic Fibrosis.
    Pickhardt PJ; Malecki K; Kloke J; Lubner MG
    AJR Am J Roentgenol; 2016 Dec; 207(6):1194-1199. PubMed ID: 27575867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Texture analysis of the liver at MDCT for assessing hepatic fibrosis.
    Lubner MG; Malecki K; Kloke J; Ganeshan B; Pickhardt PJ
    Abdom Radiol (NY); 2017 Aug; 42(8):2069-2078. PubMed ID: 28314916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of liver surface nodularity quantification on MDCT for staging hepatic fibrosis in patients with hepatitis C virus.
    Lubner MG; Jones D; Said A; Kloke J; Lee S; Pickhardt PJ
    Abdom Radiol (NY); 2018 Nov; 43(11):2980-2986. PubMed ID: 29572714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Multiparametric CT for Identification of High-Risk NAFLD.
    Lubner MG; Graffy PM; Said A; Watson R; Zea R; Malecki KM; Pickhardt PJ
    AJR Am J Roentgenol; 2021 Mar; 216(3):659-668. PubMed ID: 33474981
    [No Abstract]   [Full Text] [Related]  

  • 6. Multidetector Computed Tomography for Retrospective, Noninvasive Staging of Liver Fibrosis.
    Lubner MG; Pickhardt PJ
    Gastroenterol Clin North Am; 2018 Sep; 47(3):569-584. PubMed ID: 30115438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT texture analysis of the liver for assessing hepatic fibrosis in patients with hepatitis C virus.
    Lubner MG; Jones D; Kloke J; Said A; Pickhardt PJ
    Br J Radiol; 2019 Jan; 92(1093):20180153. PubMed ID: 30182750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Liver Segmental Volume Ratio for Noninvasive Detection of Cirrhosis: Comparison With Established Linear and Volumetric Measures.
    Furusato Hunt OM; Lubner MG; Ziemlewicz TJ; Muñoz Del Rio A; Pickhardt PJ
    J Comput Assist Tomogr; 2016; 40(3):478-84. PubMed ID: 26966951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of liver fibrosis severity using computed tomography-based liver and spleen volumetric indices in patients with chronic liver disease.
    Son JH; Lee SS; Lee Y; Kang BK; Sung YS; Jo S; Yu E
    Eur Radiol; 2020 Jun; 30(6):3486-3496. PubMed ID: 32055946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between T1 relaxation time of Gd-EOB-DTPA-enhanced MRI and liver stiffness measurement of ultrasound elastography in the evaluation of cirrhotic liver.
    Okada M; Murakami T; Yada N; Numata K; Onoda M; Hyodo T; Inoue T; Ishii K; Kudo M
    J Magn Reson Imaging; 2015 Feb; 41(2):329-38. PubMed ID: 24343840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully Automated and Explainable Liver Segmental Volume Ratio and Spleen Segmentation at CT for Diagnosing Cirrhosis.
    Lee S; Elton DC; Yang AH; Koh C; Kleiner DE; Lubner MG; Pickhardt PJ; Summers RM
    Radiol Artif Intell; 2022 Sep; 4(5):e210268. PubMed ID: 36204530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Liver Segment-to-Spleen Volume Ratio in the Staging of Hepatic Fibrosis in Patients with Hepatitis C Virus Infection.
    Lotan E; Raskin SP; Amitai MM; Kleinbaum Y; Veitsman E; Weiss P; Cohen-Ezra O; Berdichevski T; Ben-Ari Z
    Isr Med Assoc J; 2017 Apr; 19(4):251-256. PubMed ID: 28480681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic performance of tomoelastography of the liver and spleen for staging hepatic fibrosis.
    Reiter R; Tzschätzsch H; Schwahofer F; Haas M; Bayerl C; Muche M; Klatt D; Majumdar S; Uyanik M; Hamm B; Braun J; Sack I; Asbach P
    Eur Radiol; 2020 Mar; 30(3):1719-1729. PubMed ID: 31712963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
    Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
    World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion kurtosis imaging with the breath-hold technique for staging hepatic fibrosis: A preliminary study.
    Yoshimaru D; Miyati T; Suzuki Y; Hamada Y; Mogi N; Funaki A; Tabata A; Masunaga A; Shimada M; Tobari M; Nishino T
    Magn Reson Imaging; 2018 Apr; 47():33-38. PubMed ID: 29158186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma.
    Romero-Cristóbal M; Clemente-Sánchez A; Ramón E; Téllez L; Canales E; Ortega-Lobete O; Velilla-Aparicio E; Catalina MV; Ibáñez-Samaniego L; Alonso S; Colón A; Matilla AM; Salcedo M; Albillos A; Bañares R; Rincón D
    JHEP Rep; 2023 Mar; 5(3):100645. PubMed ID: 36691569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of liver fibrosis by Fibroscan as compared to liver biopsy in biliary atresia.
    Shen QL; Chen YJ; Wang ZM; Zhang TC; Pang WB; Shu J; Peng CH
    World J Gastroenterol; 2015 Jun; 21(22):6931-6. PubMed ID: 26078570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver segmental volume and attenuation ratio (LSVAR) on portal venous CT scans improves the detection of clinically significant liver fibrosis compared to liver segmental volume ratio (LSVR).
    Obmann VC; Marx C; Hrycyk J; Berzigotti A; Ebner L; Mertineit N; Gräni C; Heverhagen JT; Christe A; Huber AT
    Abdom Radiol (NY); 2021 May; 46(5):1912-1921. PubMed ID: 33156949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of diffusion-weighted MRI and dynamic Gd-EOB-DTPA-enhanced MRI for detection and staging of hepatic fibrosis in primary sclerosing cholangitis.
    Keller S; Sedlacik J; Schuler T; Buchert R; Avanesov M; Zenouzi R; Lohse AW; Kooijman H; Fiehler J; Schramm C; Yamamura J
    Eur Radiol; 2019 Feb; 29(2):818-828. PubMed ID: 30014204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNAs as predictors for liver fibrosis staging in hepatitis C virus-associated chronic liver disease patients.
    Shaker OG; Senousy MA
    J Viral Hepat; 2017 Aug; 24(8):636-644. PubMed ID: 28211229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.